Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSPD1 | P10809 | 3/20 | 0.45 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.45 |
| ▸ | HSPE1 | P61604 | 3/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.44 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.44 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.44 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117139 | 0.83 | TP53 (0.46) | HPGDKDM4ETSHRKMT2AMEN1 | |
| SCHEMBL2117286 | 0.79 | SYK (0.48) | HPGDTSHRTP53GAACYP3A4 | |
| SCHEMBL2116820 | 0.78 | GAA (0.47) | HPGDTSHRKMT2AMEN1HTT | |
| SCHEMBL2117794 | 0.77 | MAPT (0.44) | HPGDTSHRKMT2AMEN1HTT | |
| SCHEMBL2119637 | 0.75 | GAA (0.49) | HPGDTSHRKMT2AMEN1TP53 | |
| SCHEMBL2119867 | 0.74 | GAA (0.48) | HPGDKDM4ETSHRKMT2AMEN1 | |
| SCHEMBL2119710 | 0.73 | GAA (0.43) | HPGDKDM4ETSHRKMT2AHTT | |
| SCHEMBL2119912 | 0.73 | GAA (0.47) | HPGDKDM4ETSHRKMT2AMEN1 | |
| SCHEMBL259416 | 0.72 | HPGD (1.00) | HPGDKDM4ETSHRKMT2AMEN1 | |
| SCHEMBL10192087 | 0.70 | HTT (0.88) | HPGDKMT2AMEN1HTTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095012-A1 | TOLUIDINE SULFONAMIDES AND THEIR USE | ELARA PHARMACEUTICALS GMBH (DE) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095012-A1 | TOLUIDINE SULFONAMIDES AND THEIR USE | HIF1A, HIF1AN, EGLN3 | HPGD 1027/4885KDM4E 191/4885TSHR 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.